George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Oct 2023 15:02

RNS Number : 5657O
Ergomed plc
03 October 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7ZCY67

Issuer Name

ERGOMED PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

Name

City of registered office

Country of registered office

Morgan Stanley

Wilmington, Delaware

USA

4. Details of the shareholder

Name

City of registered office

Country of registered office

Morgan Stanley & Co. International plc

London

UNITED KINGDOM

5. Date on which the threshold was crossed or reached

29-Sep-2023

6. Date on which Issuer notified

03-Oct-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.134230

0.000000

5.134230

2615511

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7ZCY67

2615511

5.134230

Sub Total 8.A

2615511

5.134230%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Morgan Stanley (Chain 1)

Morgan Stanley (Chain 1)

Morgan Stanley International Holdings Inc.

Morgan Stanley (Chain 1)

Morgan Stanley International Limited

Morgan Stanley (Chain 1)

Morgan Stanley Investments (UK)

Morgan Stanley (Chain 1)

Morgan Stanley & Co. International plc

5.134230

5.134230%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

03-Oct-2023

13. Place Of Completion

Glasgow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFSAFDDEDSEIS
Date   Source Headline
14th Nov 20237:00 amRNSCancellation - Ergomed plc
13th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
13th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
13th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 202310:37 amRNSScheme of Arrangement becomes Effective
13th Nov 202310:24 amRNSForm 8.5 (EPT/RI) - Ergomed Plc
13th Nov 20237:30 amRNSSuspension - Ergomed plc
10th Nov 20233:47 pmRNSHolding(s) in Company
10th Nov 20233:30 pmRNSForm 8.3 - ERGO LN
10th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
10th Nov 20233:29 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
10th Nov 20233:15 pmPRNForm 8.3 - Ergomed Plc
10th Nov 20233:05 pmRNSHolding(s) in Company
10th Nov 202312:05 pmGNWForm 8.3 - Ergomed PLC
10th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
10th Nov 202310:50 amGNWMan Group PLC : Form 8.3 - Ergomed plc
10th Nov 202310:45 amRNSForm 8.3 - Ergomed plc
9th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
9th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
9th Nov 20232:27 pmRNSIssue of Equity and Rule 2.9 Announcement
9th Nov 20232:16 pmRNSCourt Sanction of the Scheme of Arrangement
9th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20236:00 pmRNSErgomed
8th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
8th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
8th Nov 20238:12 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
7th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
6th Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
6th Nov 20232:04 pmGNWForm 8.3 - Ergomed Plc
6th Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
6th Nov 202311:50 amRNSForm 8.3 - Ergomed plc
6th Nov 20238:34 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
3rd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
3rd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
3rd Nov 20239:33 amGNWMan Group PLC : Form 8.3 - Ergomed plc
2nd Nov 20233:30 pmGNWForm 8.3 - Ergomed plc
2nd Nov 20233:21 pmRNSStatement re Publication of Finance Documentation
2nd Nov 202312:48 pmGNWForm 8.3 - Ergomed Plc
2nd Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
2nd Nov 202311:45 amRNSForm 8.3 - Ergomed plc
2nd Nov 20237:59 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20233:20 pmRNSForm 8.3 - Ergomed plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202312:00 pmRNSForm 8.5 (EPT/RI) - Ergomed Plc
1st Nov 202311:25 amRNSForm 8.3 - Ergomed plc
1st Nov 20238:50 amRNSForm 8.5 (EPT/NON-RI) Ergomed Plc
1st Nov 20237:00 amRNSIssue of Equity and Rule 2.9 Announcement
31st Oct 20235:09 pmGNWForm 8.3 - Ergomed plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.